These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3579161)

  • 21. A simple two-step isolation procedure for human and bovine antithrombin II/III (heparin cofactor): a comparison of two methods.
    Thaler E; Schmer G
    Br J Haematol; 1975 Oct; 31(2):233-43. PubMed ID: 53066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and functional study of antithrombin III in newborn infants.
    McDonald MM; Hathaway WE; Reeve EB; Leonard BD
    Thromb Haemost; 1982 Feb; 47(1):56-8. PubMed ID: 7071806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single-step method for the isolation of antithrombin III.
    Wickerhauser M; Williams C
    Vox Sang; 1984; 47(6):397-405. PubMed ID: 6516292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fate of thrombin and thrombin-antithrombin-III complex adsorbed to a heparinized biomaterial: analysis of the enzyme-inhibitor complexes displaced by plasma.
    Hatton MW; Rollason G; Sefton MV
    Thromb Haemost; 1983 Dec; 50(4):873-7. PubMed ID: 6198746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombin III Alger: a new homozygous AT III variant.
    Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M
    Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pasteurisation induced changes in an antithrombin III concentrate.
    Winkelman L; Haddon ME
    Thromb Res; 1986 Jul; 43(2):219-27. PubMed ID: 3738862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction of heparin with plasma proteins. Demonstration of different binding sites for antithrombin III complexes and antithrombin III.
    McKay EJ; Laurell CB
    J Lab Clin Med; 1980 Jan; 95(1):69-80. PubMed ID: 7350242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of the "classical" antithrombin III deficiency.
    Sas G; Petö I; Bánhegyi D; Blaskó G; Domján G
    Thromb Haemost; 1980 Jun; 43(2):133-6. PubMed ID: 7455972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination of intravenously administered radiolabelled antithrombin III and heparin in humans.
    de Swart CA; Nijmeyer B; Andersson LO; Holmer E; Sixma JJ; Bouma BN
    Thromb Haemost; 1984 Aug; 52(1):66-70. PubMed ID: 6495266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
    de Moerloose PA; Reber G; Vernet P; Minazio P; Bouvier CA
    Thromb Haemost; 1987 Apr; 57(2):154-7. PubMed ID: 3603409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of large scale fractionation methods. VII. Preparation of antithrombin III concentrate.
    Wickerhauser M; Williams C; Mercer J
    Vox Sang; 1979; 36(5):281-93. PubMed ID: 462917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous isolation and partial characterization of antithrombin III and alpha 1-proteinase inhibitor from horse plasma.
    Kurdowska A; Koj A; Jaśkowska M
    Acta Biochim Pol; 1982; 29(1-2):95-103. PubMed ID: 6983800
    [No Abstract]   [Full Text] [Related]  

  • 33. Purification and large-scale preparation of antithrombin III.
    Hoffman DL
    Am J Med; 1989 Sep; 87(3B):23S-26S. PubMed ID: 2801726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple two-step procedure for the isolation of antithrombin III from biological fluids.
    McKay EJ
    Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):375-82. PubMed ID: 6168028
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of ultrasound on structure and functional properties of antithrombin III and proteins of PPSB complex.
    Shkumatov VM; Adzerikho IE; Lesnikovich JA; Cherniavsky EA
    Biochemistry (Mosc); 2004 Feb; 69(2):195-200. PubMed ID: 15000687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Isolation and characteristics of antithrombin III from human plasma].
    Markova OA; Kalashnikov VV; Khvatov VB
    Vopr Med Khim; 1987; 33(3):62-6. PubMed ID: 3630019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immobilization of heparin on polyacrylamide derivatives.
    Tichá M; Zelezná B; Jonáková V; Filka K
    J Chromatogr B Biomed Appl; 1994 Jun; 656(2):423-6. PubMed ID: 7987496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invalidation of concerns with long-term use of heparin: thrombin/antithrombin III interactions.
    Goosen MF; Sefton MV
    Trans Am Soc Artif Intern Organs; 1982; 28():451-5. PubMed ID: 7164279
    [No Abstract]   [Full Text] [Related]  

  • 39. Preparation of highly stable antithrombin-sepharose and utilization for the fractionation of heparin.
    Pixley R; Danishefsky I
    Thromb Res; 1982 Apr; 26(2):129-33. PubMed ID: 7112509
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis.
    Barrowcliffe TW
    Thromb Haemost; 1980 Feb; 42(5):1434-45. PubMed ID: 7368150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.